Diabetic Lumbosacral Plexopathy
No Results
No Results
processing….
Proximal neuropathy in diabetes mellitus (DM) is a condition in which patients develop severe aching or burning and lancinating pain in the hip and thigh. This is followed by weakness and wasting of the thigh muscles, which often occur asymmetrically. This disabling condition occurs in type 1 and type 2 DM. Bruns first described the disorder in patients with DM in 1890. [1] In 1955, Garland coined the term diabetic amyotrophy, although the name Bruns-Garland syndrome is also used to describe the condition. [2, 3, 4]
Diabetic amyotrophy, which is distinct from other types of diabetic neuropathy, usually has its onset during or after middle age (although it can occur in younger individuals). Concomitant distal, predominantly sensory neuropathy may exist. The results of most electrodiagnostic studies are consistent with the presence of a neurogenic lesion that could be associated with lumbosacral plexopathy, radiculopathy, or proximal crural neuropathy. [5, 6, 7, 8] However, the exact cause of diabetic lumbosacral plexopathy is not known. [9]
If, as often occurs, the pathology of lumbosacral plexopathy involves not only the plexus but also the root and nerve levels, the disorder is called lumbosacral radiculoplexus neuropathy. [10]
For more information, see Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus, Diabetic Neuropathy, and Electrophysiology.
In evaluating suspected diabetic lumbosacral plexopathy, neural and electrophysiologic studies are generally helpful. Laboratory tests used to diagnose or assess control of diabetes mellitus (eg, fasting blood glucose, hemoglobin A1C) should be performed.
In addition, lumbar puncture results may show elevated cerebrospinal fluid (CSF) proteins, sometimes more than 1 g. [11] Additional laboratory studies to rule out other causes of neuropathy, as well as cancer and bleeding diathesis, are also important.
Lumbar spine and pelvic radiographs should be performed to evaluate for other causes of the plexopathy. Computed tomography (CT) scanning or magnetic resonance imaging (MRI) of the lumbosacral spine and pelvis may be indicated in some cases to rule out mass lesions. [12] Electromyography (EMG) and nerve conduction studies (NCS) should also be performed. [13, 14]
Good glycemic control through the adjustment of diabetes medication (eg, oral agents, insulin) is of paramount importance. Education on proper diet and exercise is also essential.
Medical management includes neuromodulator medications for chronic neuropathic pain management such as anticonvulsant medications (gabapentin or pregabalin) and selective norepinephrine reuptake inhibitors (such as duloxetine). Anecdotal experience indicates that topical counter-irritant medications such as menthol and wintergreen are also valuable as comfort measures.
A physical therapist (PT) can assist in improving a patient’s functional mobility (eg, transfers, ambulation). The PT instructs the patient in the use of assistive devices when necessary. A therapeutic exercise and range-of-motion program supervised by the PT is helpful in maintaining and improving lower extremity prime-mover muscle function and avoiding major lower extremity joint contractures.
An occupational therapist can recommend appropriate adaptive equipment (eg, a reacher, an elevated toilet seat, a tub bench) based on the degree of proximal weakness the patient is experiencing.
The underlying pathogenesis of diabetic lumbosacral plexopathy and the site of the lesion are not clearly understood and remain subjects of controversy. [5, 15] The condition is most likely caused by inflammatory, immune-mediated vascular radiculoplexopathy. [16, 17, 18, 19] Most authors now favor an immune vasculopathy as the cause of diabetic amyotrophy. Studies suggest a role for immunomodulating agents in certain types of diabetic neuropathy, including diabetic amyotrophy. [20]
A study by Kotov et al of 445 patients with diabetes mellitus found that diabetic asymmetrical proximal neuropathy was present in 7.9% of this group and that the rate of occurrence was higher in patients with type 2 diabetes mellitus, in those with poorly controlled glycemia, and in patients who had had diabetes for over 5 years. [21]
In the United States, the overall prevalence of diabetic lumbosacral plexopathy among individuals with diabetes is 0.08%, although the condition occurs more frequently in persons with type 2 diabetes (1.1%) than in those with the type 1 disease (0.3%).
In a study of the population of Olmstead County, Minn., Ng et al found the rate of DM in persons with lumbosacral radiculoplexus neuropathy to be 66.1%, compared with 19.8% in controls. [22]
Morbidity related to diabetic lumbosacral plexopathy is mainly secondary to pain, proximal muscle wasting, and weakness, causing difficulty getting up from a chair and climbing stairs.
No race or sex predilection exists for diabetic lumbosacral plexopathy; however, the condition occurs most commonly in patients aged 50 years or older. In a series of 12 cases reported by Casey and Harrison, no patient was younger than 50 years, and 10 patients were older than 60 years. [23] In a large series of 105 patients with diabetic amyotrophy reported by Bastron and Thomas, the age of onset ranged from 36 to 83 years; symptoms progressed over an average of 6.2 months, with 9.5% of patients having painless muscle weakness. [24] Diabetic lumbosacral plexopathy is rare in children; only 3 cases of the condition in children aged 13-16 years have been reported in the literature.
Good functional recovery within 12-24 months is expected in 60% of patients with diabetic lumbosacral plexopathy, although mild weakness, discomfort, and stiffness often persist for years. Occasional relapses can occur.
The patient should be educated in the importance of good glycemic control in conjunction with proper diet and exercise. [25] During rehabilitation, in order to improve functional recovery, the patient should be taught exercises to regain strength in the affected muscle groups.
Bruns L. Uberneuritsche lahmungen beim diabetes mellitus. Berl Klin Wochenschr. 1890. 27:509-15.
GARLAND H. Diabetic amyotrophy. Br Med J. 1955 Nov 26. 2(4951):1287-90. [Medline]. [Full Text].
Asbury AK. Proximal diabetic neuropathy. Ann Neurol. 1977 Sep. 2(3):179-80. [Medline].
Locke S, Lawrence DG, Legg MA. Diabetic amyotrophy. Am J Med. 1963 Jun. 34:775-85. [Medline].
Sander HW, Chokroverty S. Diabetic amyotrophy: current concepts. Semin Neurol. 1996 Jun. 16(2):173-8. [Medline].
Tracy JA, Dyck PJ. The spectrum of diabetic neuropathies. Phys Med Rehabil Clin N Am. 2008 Feb. 19(1):1-26, v. [Medline]. [Full Text].
Raff MC, Asbury AK. Ischemic mononeuropathy and mononeuropathy multiplex in diabetes mellitus. N Engl J Med. 1968 Jul 4. 279(1):17-21. [Medline].
Taylor BV, Dunne JW. Diabetic amyotrophy progressing to severe quadriparesis. Muscle Nerve. 2004 Oct. 30(4):505-9. [Medline].
Brown MJ, Asbury AK. Diabetic neuropathy. Ann Neurol. 1984 Jan. 15(1):2-12. [Medline].
Dyck PJ, Thaisetthawatkul P. Lumbosacral plexopathy. Continuum (Minneap Minn). 2014 Oct. 20 (5 Peripheral Nervous System Disorders):1343-58. [Medline].
Imtiaz KE, Lekwuwa G, Kaimal N, Rai M, Nafeez M, Majeed T. Elevated cerebrospinal fluid protein in diabetic lumbosacral radiculoplexus neuropathy. QJM. 2012 Nov. 105 (11):1119-23. [Medline].
O’Neill BJ, Flanders AE, Escandon SL, Tahmoush AJ. Treatable lumbosacral polyradiculitis masquerading as diabetic amyotrophy. J Neurol Sci. 1997 Oct 22. 151(2):223-5. [Medline].
Tataroglu C, Bicerol B, Kiylioglu N, Ozkul A, Akyol A. Proximal femoral conductions in patients with lumbosacral radiculoplexus neuropathy. Clin Neurol Neurosurg. 2007 Oct. 109(8):654-60. [Medline].
Subramony SH, Wilbourn AJ. Diabetic proximal neuropathy. Clinical and electromyographic studies. J Neurol Sci. 1982 Feb. 53(2):293-304. [Medline].
Williams IR, Mayer RF. Subacute proximal diabetic neuropathy. Neurology. 1976 Feb. 26(2):108-16. [Medline].
Dyck PJ, Norell JE, Dyck PJ. Microvasculitis and ischemia in diabetic lumbosacral radiculoplexus neuropathy. Neurology. 1999 Dec 10. 53(9):2113-21. [Medline].
Harrison MJ, Casey EB. Diabetic amyotrophy. Br Med J. 1972 Jul 29. 3(5821):293. [Medline]. [Full Text].
Pascoe MK, Low PA, Windebank AJ, Litchy WJ. Subacute diabetic proximal neuropathy. Mayo Clin Proc. 1997 Dec. 72(12):1123-32. [Medline].
Kawamura N, Dyck PJ, Schmeichel AM, Engelstad JK, Low PA, Dyck PJ. Inflammatory mediators in diabetic and non-diabetic lumbosacral radiculoplexus neuropathy. Acta Neuropathol. 2008 Feb. 115(2):231-9. [Medline].
Dyck PJ, Windebank AJ. Diabetic and nondiabetic lumbosacral radiculoplexus neuropathies: new insights into pathophysiology and treatment. Muscle Nerve. 2002 Apr. 25(4):477-91. [Medline].
Kotov SV, Rudakova IG, Isakova EV, et al. [Diabetic asymmetric proximal neuropathy]. Zh Nevrol Psikhiatr Im S S Korsakova. 2017. 117 (1):59-62. [Medline].
Ng PS, Dyck PJ, Laughlin RS, Thapa P, Pinto MV, Dyck PJB. Lumbosacral radiculoplexus neuropathy: incidence and the association with diabetes mellitus. Neurology. 2019 Feb 13. [Medline].
Casey EB, Harrison MJ. Diabetic amyotrophy: a follow-up study. Br Med J. 1972 Mar 11. 1(5801):656-9. [Medline]. [Full Text].
Bastron JA, Thomas JE. Diabetic polyradiculopathy: clinical and electromyographic findings in 105 patients. Mayo Clin Proc. 1981 Dec. 56(12):725-32. [Medline].
Gulve EA. Exercise and glycemic control in diabetes: benefits, challenges, and adjustments to pharmacotherapy. Phys Ther. 2008 Nov. 88(11):1297-321. [Medline].
Russell JW, Berent-Spillson A, Vincent AM, Freimann CL, Sullivan KA, Feldman EL. Oxidative injury and neuropathy in diabetes and impaired glucose tolerance. Neurobiol Dis. 2008 Jun. 30(3):420-9. [Medline]. [Full Text].
Barohn RJ, Sahenk Z, Warmolts JR, Mendell JR. The Bruns-Garland syndrome (diabetic amyotrophy). Revisited 100 years later. Arch Neurol. 1991 Nov. 48(11):1130-5. [Medline].
Gupta G, Massie R, Doherty TJ, et al. Diabetic Cranio-Cervico-Radiculoplexus Neuropathy. PM R. 2015 May 12. [Medline].
Matsuda N, Kobayashi S, Ugawa Y. [Skeletal muscle magnetic resonance imaging study in a patient with diabetic lumbosacral radiculoplexus neuropathy]. Rinsho Shinkeigaku. 2014. 54(9):751-4. [Medline].
Deroide N, Bousson V, Mambre L, et al. Muscle MRI STIR signal intensity and atrophy are correlated to focal lower limb neuropathy severity. Eur Radiol. 2014 Sep 26. [Medline].
McCormack EP, Alam M, Erickson NJ, Cherrick AA, Powell E, Sherman JH. Use of MRI in diabetic lumbosacral radiculoplexus neuropathy: case report and review of the literature. Acta Neurochir (Wien). 2018 Sep 10. [Medline].
Younger DS. Diabetic lumbosacral radiculoplexus neuropathy: a postmortem studied patient and review of the literature. J Neurol. 2011 Jul. 258(7):1364-7. [Medline].
Tracy JA, Engelstad JK, Dyck PJ. Microvasculitis in diabetic lumbosacral radiculoplexus neuropathy. J Clin Neuromuscul Dis. 2009 Sep. 11(1):44-8. [Medline].
Kazamel M, Dyck PJ. Sensory manifestations of diabetic neuropathies: anatomical and clinical correlations. Prosthet Orthot Int. 2015 Feb. 39 (1):7-16. [Medline].
Fernandes Filho JA, Nathan BM, Palmert MR, Katirji B. Diabetic amyotrophy in an adolescent responsive to intravenous immunoglobulin. Muscle Nerve. 2005 Dec. 32(6):818-20. [Medline].
Kawagashira Y, Watanabe H, Oki Y, Iijima M, Koike H, Hattori N, et al. Intravenous immunoglobulin therapy markedly ameliorates muscle weakness and severe pain in proximal diabetic neuropathy. J Neurol Neurosurg Psychiatry. 2007 Aug. 78(8):899-901. [Medline]. [Full Text].
Wada Y, Yanagihara C, Nishimura Y, Oka N. A case of diabetic amyotrophy with severe atrophy and weakness of shoulder girdle muscles showing good response to intravenous immune globulin. Diabetes Res Clin Pract. 2007 Jan. 75(1):107-10. [Medline].
Kilfoyle D, Kelkar P, Parry GJ. Pulsed methylprednisolone is a safe and effective treatment for diabetic amyotrophy. J Clin Neuromuscul Dis. 2003 Jun. 4(4):168-70. [Medline].
Dyck PJB, O’Brien P, Bosch EP, et al. The multi-center, double-blind controlled trial of IV methylprednisolone in diabetic lumbosacral radiculoplexus neuropathy. Neurology. Feb 2006. 66(5 Suppl 2):A191.
Chan YC, Lo YL, Chan ES. Immunotherapy for diabetic amyotrophy. Cochrane Database Syst Rev. 2009 Jul 8. CD006521. [Medline].
Chan YC, Lo YL, Chan ES. Immunotherapy for diabetic amyotrophy. Cochrane Database Syst Rev. 2012 Jun 13. 6:CD006521. [Medline].
Chan YC, Lo YL, Chan ES. Immunotherapy for diabetic amyotrophy. Cochrane Database Syst Rev. 2017 Jul 26. 7:CD006521. [Medline].
Divakara Kedlaya, MBBS Medical Director, Physical Medicine and Rehabilitation and Pain Management, St Mary Corwin Medical Center
Divakara Kedlaya, MBBS is a member of the following medical societies: American Academy of Physical Medicine and Rehabilitation, American Association of Neuromuscular and Electrodiagnostic Medicine
Disclosure: Nothing to disclose.
Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference
Disclosure: Received salary from Medscape for employment. for: Medscape.
Aishwarya Patil, MD Physiatrist (Rehabilitation Physician), Vice Chair, Immanuel Rehabilitation Center
Aishwarya Patil, MD is a member of the following medical societies: American Academy of Physical Medicine and Rehabilitation, American Association of Neuromuscular and Electrodiagnostic Medicine, Association of Academic Physiatrists, Association of Physicians of India
Disclosure: Nothing to disclose.
Milton J Klein, DO, MBA Consulting Physiatrist, Heritage Valley Health System-Sewickley Hospital and Ohio Valley General Hospital
Milton J Klein, DO, MBA is a member of the following medical societies: American Academy of Disability Evaluating Physicians, American Academy of Medical Acupuncture, American Academy of Osteopathy, American Academy of Physical Medicine and Rehabilitation, American Medical Association, American Osteopathic Association, American Osteopathic College of Physical Medicine and Rehabilitation, American Pain Society, Pennsylvania Medical Society
Disclosure: Nothing to disclose.
Teresa L Massagli, MD Professor of Rehabilitation Medicine, Adjunct Professor of Pediatrics, University of Washington School of Medicine
Teresa L Massagli, MD is a member of the following medical societies: Academy of Spinal Cord Injury Professionals, American Academy of Physical Medicine and Rehabilitation, Association of Academic Physiatrists
Disclosure: Nothing to disclose.
Diabetic Lumbosacral Plexopathy
Research & References of Diabetic Lumbosacral Plexopathy|A&C Accounting And Tax Services
Source
0 Comments